ResearcherTongji UniversityActive in the last 2 years
Qing Xu
Matched on ORCID iD 0000-0002-4785-2994; OpenAlex author ID A5103047257. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2012: 1 paper · 2013: none · 2014: 1 paper · 2015: 2 papers · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 7
- Correction: PABPC1 silencing inhibits pancreatic cancer cell proliferation and EMT, and induces apoptosis via PI3K/AKT pathway. Co-author DOI 10.1007/s10616-025-00760-4↗
- PABPC1 silencing inhibits pancreatic cancer cell proliferation and EMT, and induces apoptosis via PI3K/AKT pathway. Co-author DOI 10.1007/s10616-024-00626-1↗
- Targeting tumor-associated macrophages to combat pancreatic cancer. Co-author DOI 10.18632/oncotarget.9383↗
- Transcriptomic analysis of pancreatic cancer cells in response to metformin and aspirin: an implication of synergy. Co-author DOI 10.1038/srep13390↗
- Metformin combined with aspirin significantly inhibit pancreatic cancer cell growth in vitro and in vivo by suppressing anti-apoptotic proteins Mcl-1 and Bcl-2. Co-author DOI 10.18632/oncotarget.4126↗
- Prognostic value of human equilibrative nucleoside transporter1 in pancreatic cancer receiving gemcitabin-based chemotherapy: a meta-analysis. Last author DOI 10.1371/journal.pone.0087103↗
- High level interleukin-6 in the medium of human pancreatic cancer cell culture suppresses production of neurotransmitters by PC12 cell line. Co-author DOI 10.1007/s11011-011-9270-x↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Changren Zhu · 2 shared papers, 2024–2025 · strength 0.56
- Paper Correction: PABPC1 silencing inhibits pancreatic cancer cell proliferation and EMT, and induces apoptosis via PI3K/AKT … DOI 10.1007/s10616-025-00760-4↗
- Paper PABPC1 silencing inhibits pancreatic cancer cell proliferation and EMT, and induces apoptosis via PI3K/AKT pathway. DOI 10.1007/s10616-024-00626-1↗
- Jun Zheng · 2 shared papers, 2024–2025 · strength 0.56
- Paper Correction: PABPC1 silencing inhibits pancreatic cancer cell proliferation and EMT, and induces apoptosis via PI3K/AKT … DOI 10.1007/s10616-025-00760-4↗
- Paper PABPC1 silencing inhibits pancreatic cancer cell proliferation and EMT, and induces apoptosis via PI3K/AKT pathway. DOI 10.1007/s10616-024-00626-1↗
- Xiang‐Lin Tan · 3 shared papers, 2015–2016 · strength 0.17
- Paper Targeting tumor-associated macrophages to combat pancreatic cancer. DOI 10.18632/oncotarget.9383↗
- Paper Transcriptomic analysis of pancreatic cancer cells in response to metformin and aspirin: an implication of synergy. DOI 10.1038/srep13390↗
- Paper Metformin combined with aspirin significantly inhibit pancreatic cancer cell growth in vitro and in vivo by suppressing… DOI 10.18632/oncotarget.4126↗
- Wen Yue · 3 shared papers, 2015–2016 · strength 0.17
- Paper Targeting tumor-associated macrophages to combat pancreatic cancer. DOI 10.18632/oncotarget.9383↗
- Paper Transcriptomic analysis of pancreatic cancer cells in response to metformin and aspirin: an implication of synergy. DOI 10.1038/srep13390↗
- Paper Metformin combined with aspirin significantly inhibit pancreatic cancer cell growth in vitro and in vivo by suppressing… DOI 10.18632/oncotarget.4126↗
- Ran Cui · 1 shared paper, 2016 · strength 0.07
- Xi Zheng · 1 shared paper, 2015 · strength 0.05
- Darren R. Carpizo · 1 shared paper, 2015 · strength 0.05
- Zhuqing Liu · 1 shared paper, 2014 · strength 0.04
- Madeline Li · 1 shared paper, 2012 · strength 0.03
- Gary Rodin · 1 shared paper, 2012 · strength 0.03
- Rong Li · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.